研究者業績

福田 久

Hisashi Fukuda

基本情報

所属
自治医科大学 医学部 内科学講座 消化器内科学部門 / 附属病院消化器センター・内科部門

J-GLOBAL ID
202201009217245727
researchmap会員ID
R000036812

論文

 52
  • Yuji Ino, Hisashi Fukuda, Takashi Ueno, Hiroki Hayashi, Yoshie Nomoto, Haruo Takahashi, Hironori Yamamoto
    Endoscopy 56(S 01) E880-E881 2024年12月  
  • Yuka Kagaya, Yoshikazu Hayashi, Takaaki Morikawa, Hiroki Hayashi, Hisashi Fukuda, Stefano Kayali, Hironori Yamamoto
    Endoscopy 56(S 01) E620-E621 2024年12月  
  • Kosei Hashimoto, Hisashi Fukuda, Toshihiro Fujinuma, Edward J Despott, Hironori Yamamoto
    Endoscopy 56(S 01) E542-E543 2024年12月  
  • Yuka Kowazaki, Hisashi Fukuda, Tetsurou Miwata, Takaaki Morikawa, Sawako Fujikura, Jun Ushio
    Endoscopy international open 12(10) E1196-E1198 2024年10月  責任著者
  • Kazuya Takahashi, Hiroki Sato, Yuto Shimamura, Hirofumi Abe, Hironari Shiwaku, Junya Shiota, Chiaki Sato, Kenta Hamada, Masaki Ominami, Yoshitaka Hata, Hisashi Fukuda, Ryo Ogawa, Jun Nakamura, Tetsuya Tatsuta, Yuichiro Ikebuchi, Shuji Terai, Haruhiro Inoue
    Journal of gastroenterology 2024年5月30日  
    BACKGROUND: Symptom scales for achalasia after per-oral endoscopic myotomy (POEM) are lacking. This study aimed to propose a new scale based on the conventional Eckardt score (c-ES) and evaluate persistent symptoms that impair patients' quality of life (QOL) post-POEM. METHODS: Dysphagia, regurgitation, and chest pain frequencies were assessed using a 6-point scale modified-ES (m-ES) after POEM, with "occasional" symptoms on the c-ES further subdivided into three-period categories on m-ES. Symptom severity was further evaluated using a 5-point scale ranging from 1 to 5 points, with a score ≥ 3 points defined as persistent symptoms impairing QOL. We analyzed the correlation between the m-ES and severity score, diagnostic performance of the m-ES for persistent symptoms, and overlaps between each residual symptom. RESULTS: Overall, 536 patients (median follow-up period, 2.9 years) post-POEM were included in this multicenter study. Significant correlations were observed between the m-ES and severity scores for dysphagia (r = 0.67, p < 0.01), regurgitation (r = 0.73, p < 0.01), and chest pain (r = 0.85, p < 0.01). Twenty-six patients (4.9%) had persistent symptoms post-POEM, and 23 of them had m-ES-specific symptom frequency ≥ once a month, which was determined as the optimal frequency threshold for screening persistent symptoms. The total m-ES predicted persistent symptoms more accurately than the total c-ES (area under the curve: 0.95 vs. 0.79, p < 0.01). Furthermore, dysphagia and chest pain were the major residual symptoms post-POEM covering 91.4% of regurgitation. CONCLUSIONS: The new post-POEM scale successfully evaluated the QOL-based patient symptom severities. Our study implied the possibility of a simpler scale using residual dysphagia and chest pain.

MISC

 87